Schedule 13G ownership disclosure

UNICYCIVE THERAPEUTICS INC

Common Stock, par value $0.001 per share · CUSIP: 90466Y103

Event date: 2024-09-30

Filing-level shares
7,887,836.00
Percent of class
7.76%
  • NANTAHALA CAPITAL PARTNERS LIMITED PARTNERSHIP

    Shares: 7,887,836.00 · Class: 7.76%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001104659-24-119183
Form type
SCHEDULE 13G/A
Filer
Nantahala Capital Partners Limited Partnership
CIK
CIK 1502725
Filed
Nov 14, 2024
Reporting period
Sep 30, 2024
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub